Proposal-writing workshop with MEDVIA and VLAIO kicks off on 13 March

MEDVIA is hosting a three-day proposal-writing workshop to support our Call 2023.1. Members of consortia whose Abstracts have been approved and can move ahead to the full proposal stage are required to attend these full-day workshops to support the proposal-writing process.

Anyone can, however, attend the workshops, which are relevant for any applications being submitted for funding. Half of every workshop will be dedicated to writing, including one-on-one assistance from MEDVIA or VLAIO staff, or an outside expert.

There are three monthly workshops, each focused on a stage in the proposal-writing process:

13 March: Kickstarting the proposal-writing process
– Overview procedure full proposal
– Evaluation criteria and guidelines for your proposal
– Do’s & Don’ts innovation goals
– Formulate strong research hypothesis
– Illustrating the strong expertise of your consortium
– How to create a compelling visual of your approach

18 April: Creating a solid description of the impact of your project
– What is needed for a strong valorization case demonstrating impact
– Describing a clear business model
– How to calculate (societal) impact according to VLAIO regulations

22 May: Heading towards the final text
– Creating a strong work plan
– Milestones & deliverables
– Project planning & budget
– Risk assessment

The workshop series is free and mandatory for members of consortia whose Abstract has been approved and are moving on to full proposal.

Other fees are as follows:

Free for MEDVIA Carry and Cultivate members
€300 for MEDVIA Connect members
€2,250 Non-members

Participants needing to pay a fee will receive an invoice, which needs to be paid prior to the first workshop. The location and exact times of the workshops will be announced shortly.

Register here!

Share this article

More news on this topic

Better together

and are joining forces in a brand new organization

The members of MEDVIA and flanders.bio have voted to merge their activities in the first half of 2025. With a united voice, we will champion the entire healthtech and biotech ecosystem on the regional, federal and European stage.

The merger allows MEDVIA and flanders.bio to align activities and deliver more powerful support for our collective members. We will achieve greater impact with more dynamic networking opportunities, better directed funding and increased efficiency, sharpening our focus in common areas and drafting strategic roadmaps for Flanders.